The treatment success rate for patients treated for extensively drug-resistant tuberculosis in India was not detailed for 2023, but the forecasted data from 2024 to 2028 indicates a steady upward trend. Starting from 51 in 2024, the rate is expected to increase slightly each year, reaching 56 by 2028. Year-on-year variations suggest a budding positive trajectory with an average annual growth. Over the five-year period, this indicates a compound annual growth rate (CAGR) of around 2% in the success rate.
Future trends to watch include the impact of new treatment protocols, technology-driven diagnostics, and improved healthcare infrastructure, which could accelerate success rates beyond current forecasts. Monitoring government interventions and international collaborations will also be crucial in enhancing treatment outcomes.
